Funding for this research was provided by:
Deutschen Konsortium für Translationale Krebsforschung
Technische Universität München
Received: 21 December 2020
Accepted: 19 July 2021
First Online: 31 July 2021
: This study was approved by ethical committees of all DKTK partner sites and informed consent to participate has been given by patients included into this trial.
: All authors have given consent for publication.
: No competing interest exists by any of the authors.